European Archives - Page 60 of 1370 - European Medical Journal

Dupilumab Improves Quality of Life in Chronic Urticaria

A phase 3 trial shows dupilumab significantly improves quality of life in omalizumab-naïve patients with chronic spontaneous urticaria.

Dual Approach Shows Promise in Advanced KRAS G12C-Mutated Lung Cancer

Dual Approach Shows Promise in Advanced KRAS G12C-Mutated Lung Cancer

Combining glecirasib and sitneprotafib shows encouraging efficacy and safety in patients with KRAS G12C-mutated NSCLC.

New Stem Cell Approach Paves Way for Type 1 Diabetes Cure

New Stem Cell Approach Paves Way for Type 1 Diabetes Cure

Scientists used a chemotherapy-free stem cell approach to reverse type 1 diabetes in mice, restoring insulin production and immune balance without long-term medication.

UK Immunology Services Facing Critical Workforce Shortages

UK Immunology Services Facing Critical Workforce Shortages

A new BSI-CIPN report warns that UK clinical immunology and allergy services are critically understaffed, calling for urgent national workforce planning and investment.

S100A11 -HK2

S100A11-HK2 Axis Emerges as Promising Target in MASH

Silencing S100A11 protects against steatosis, inflammation and fibrosis in murine MASH, uncovering HK2 as a key metabolic driver and potential therapeutic target.

igh Cardiorespiratory Fitness Linked to Lower Risk of Urinary Tract Cancers

High Cardiorespiratory Fitness Linked to Lower Risk of Urinary Tract Cancers

A large Norwegian study shows that higher cardiorespiratory fitness is linked to a significantly lower long-term risk of urinary tract, bladder, and kidney cancers.

dementia biomarkers

Dementia Biomarkers Track Early Cognitive Decline

Blood based dementia biomarkers reveal which patients with memory concerns are most likely to worsen.

Kefir Shows Potential as a Natural Strategy for Osteoporosis Management

A new review highlights kefir-derived peptides, probiotics and kefiran as promising natural strategies for bone health and osteoporosis prevention.

Personalised CRISPR Therapy Success in Baby With Rare Disorder

A world-first personalised CRISPR base-editing therapy has shown promising early results in an infant with CPS1 deficiency, demonstrating the potential of rapid, bespoke gene-editing treatments for ultra-rare genetic diseases.

pancreatic cancer

Targeted Drug Shows Promise in Aggressive Pancreatic Cancer

Garsorasib shrank tumours in nearly half of patients with KRAS G12C pancreatic cancer and showed manageable side effects.